ATE219931T1 - Darmlösliche grannulatkörner enthaltende tablette - Google Patents

Darmlösliche grannulatkörner enthaltende tablette

Info

Publication number: ATE219931T1
Authority: AT; Austria
Prior art keywords: tablet; granules; enteric; tableting; reduced
Prior art date: 1993-10-12

Application number

AT94929012T

Other languages

English (en)

Inventor

Tomohisa Matsushita

Mitsuo Hashimoto

Original Assignee

Mitsubishi Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-12

Filing date

1994-10-06

Publication date

2002-07-15

1994-10-06 Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp

2002-07-15 Application granted granted Critical

2002-07-15 Publication of ATE219931T1 publication Critical patent/ATE219931T1/de

Links

239000008187 granular material Substances 0.000 title abstract 7
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 2
229940079593 drug Drugs 0.000 abstract 2
239000003814 drug Substances 0.000 abstract 2
YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
BWZOPYPOZJBVLQ-UHFFFAOYSA-K aluminium glycinate Chemical compound O[Al+]O.NCC([O-])=O BWZOPYPOZJBVLQ-UHFFFAOYSA-K 0.000 abstract 1
229940024545 aluminum hydroxide Drugs 0.000 abstract 1
RJZNFXWQRHAVBP-UHFFFAOYSA-I aluminum;magnesium;pentahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Al+3] RJZNFXWQRHAVBP-UHFFFAOYSA-I 0.000 abstract 1
239000007931 coated granule Substances 0.000 abstract 1
239000011248 coating agent Substances 0.000 abstract 1
238000000576 coating method Methods 0.000 abstract 1
GDVKFRBCXAPAQJ-UHFFFAOYSA-A dialuminum;hexamagnesium;carbonate;hexadecahydroxide Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Al+3].[Al+3].[O-]C([O-])=O GDVKFRBCXAPAQJ-UHFFFAOYSA-A 0.000 abstract 1
229940015826 dihydroxyaluminum aminoacetate Drugs 0.000 abstract 1
239000000945 filler Substances 0.000 abstract 1
229960001545 hydrotalcite Drugs 0.000 abstract 1
229910001701 hydrotalcite Inorganic materials 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
235000017557 sodium bicarbonate Nutrition 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT94929012T 1993-10-12 1994-10-06 Darmlösliche grannulatkörner enthaltende tablette ATE219931T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP25404993		1993-10-12
PCT/JP1994/001675 WO1995010264A1 (en)	1993-10-12	1994-10-06	Tablet containing enteric granules

Publications (1)

Publication Number	Publication Date
ATE219931T1 true ATE219931T1 (de)	2002-07-15

Family

ID=17259525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94929012T ATE219931T1 (de)	1993-10-12	1994-10-06	Darmlösliche grannulatkörner enthaltende tablette

Country Status (12)

Country	Link
US (1)	US5798120A (de)
EP (1)	EP0723777B1 (de)
JP (1)	JP3710473B2 (de)
KR (1)	KR100353384B1 (de)
AT (1)	ATE219931T1 (de)
AU (1)	AU683092B2 (de)
CA (1)	CA2173506C (de)
DE (1)	DE69430921T2 (de)
DK (1)	DK0723777T3 (de)
ES (1)	ES2179079T3 (de)
PT (1)	PT723777E (de)
WO (1)	WO1995010264A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CZ289804B6 (cs) *	1994-07-08	2002-04-17	Astrazeneca Ab	Multijednotková tabletovaná dávková forma I
SE9402431D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
SE9500422D0 (sv) *	1995-02-06	1995-02-06	Astra Ab	New oral pharmaceutical dosage forms
US6645988B2 (en)	1996-01-04	2003-11-11	Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6699885B2 (en) *	1996-01-04	2004-03-02	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and methods of using same
SE9600070D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral pharmaceutical dosage forms
SE512835C2 (sv) *	1996-01-08	2000-05-22	Astrazeneca Ab	Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
SE9600072D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients II
SE9600071D0 (sv)	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
AU5446798A (en) *	1996-11-27	1998-06-22	Procter & Gamble Company, The	Compositions and methods for the treatment of gastrointestinal disorders
JP3870470B2 (ja) *	1997-02-07	2007-01-17	大正製薬株式会社	マルチプルユニットタイプ徐放性錠剤
US6096340A (en) *	1997-11-14	2000-08-01	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6174548B1 (en)	1998-08-28	2001-01-16	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
KR20010034770A (ko) *	1998-04-17	2001-04-25	우에하라 아끼라	멀티플 유닛 타입 서방성 정제
KR100554924B1 (ko)	1998-05-18	2006-03-03	다케다 야쿠힌 고교 가부시키가이샤	구강내 붕괴 정제
KR100536783B1 (ko) *	1998-07-28	2005-12-14	다케다 야쿠힌 고교 가부시키가이샤	급속 붕해성 고체 제제
US6733778B1 (en)	1999-08-27	2004-05-11	Andrx Pharmaceuticals, Inc.	Omeprazole formulation
US6544556B1 (en) *	2000-09-11	2003-04-08	Andrx Corporation	Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
EP1603537A4 (de) *	2003-02-20	2009-11-04	Santarus Inc	Neuartige formulierung, antazidkomplex-immediatfreisetzung für eine schnelle und anhaltende unterdrückung von magensäure
CN100558726C (zh) *	2003-02-24	2009-11-11	田边三菱制药株式会社	泰妥拉唑的对映体及其在治疗中的应用
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7670624B2 (en) *	2004-01-29	2010-03-02	Astella Pharma Inc.	Gastrointestinal-specific multiple drug release system
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en)	2004-05-25	2014-08-26	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
HUE040311T2 (hu)	2006-04-04	2019-02-28	Kg Acquisition Llc	Vérlemezke aggregációt gátló szert és sav inhibitort tartalmazó orális dózisformák
WO2007138606A2 (en) *	2006-06-01	2007-12-06	Dexcel Pharma Technologies Ltd.	Multiple unit pharmaceutical formulation
JP5041774B2 (ja) *	2006-09-22	2012-10-03	日本ケミファ株式会社	メサラジンを有効成分として含有する徐放性錠剤
JP4329947B1 (ja) *	2009-01-20	2009-09-09	ライオン株式会社	内服用錠剤
CN102198131A (zh) *	2010-03-24	2011-09-28	济南瑞安药业发展有限公司	一种含有奥美拉唑的新的复方制剂
WO2012074110A1 (ja) *	2010-12-03	2012-06-07	武田薬品工業株式会社	口腔内崩壊錠
US20170042806A1 (en)	2015-04-29	2017-02-16	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB971486A (en) *	1960-04-01	1964-09-30	Rech S Pharma Et Scient	Therapeutic compositions comprising aspirin and polysiloxanes
CA1259924A (en) *	1985-03-25	1989-09-26	Wallace E. Becker	Pharmaceutical tableting method
US4874614A (en) *	1985-03-25	1989-10-17	Abbott Laboratories	Pharmaceutical tableting method
CA1327010C (en) *	1986-02-13	1994-02-15	Tadashi Makino	Stabilized solid pharmaceutical composition containing antiulcer benzimidazole compound and its production
JPH0780754B2 (ja) *	1986-08-06	1995-08-30	エーザイ株式会社	多顆粒型持続性錠剤
JP2514078B2 (ja) *	1988-08-22	1996-07-10	エスエス製薬株式会社	圧縮成型製剤
JP2781442B2 (ja) *	1990-02-19	1998-07-30	旭化成工業株式会社	顆粒含有錠剤
JP2856485B2 (ja) *	1990-03-07	1999-02-10	旭化成工業株式会社	顆粒含有錠

1994
- 1994-10-06 AT AT94929012T patent/ATE219931T1/de active
- 1994-10-06 AU AU78222/94A patent/AU683092B2/en not_active Expired
- 1994-10-06 ES ES94929012T patent/ES2179079T3/es not_active Expired - Lifetime
- 1994-10-06 JP JP51158095A patent/JP3710473B2/ja not_active Expired - Lifetime
- 1994-10-06 US US08/624,510 patent/US5798120A/en not_active Expired - Lifetime
- 1994-10-06 EP EP94929012A patent/EP0723777B1/de not_active Expired - Lifetime
- 1994-10-06 DE DE69430921T patent/DE69430921T2/de not_active Expired - Lifetime
- 1994-10-06 WO PCT/JP1994/001675 patent/WO1995010264A1/ja not_active Ceased
- 1994-10-06 CA CA002173506A patent/CA2173506C/en not_active Expired - Lifetime
- 1994-10-06 PT PT94929012T patent/PT723777E/pt unknown
- 1994-10-06 DK DK94929012T patent/DK0723777T3/da active
- 1994-10-06 KR KR1019960701804A patent/KR100353384B1/ko not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2173506A1 (en)	1995-04-20
KR960704531A (ko)	1996-10-09
US5798120A (en)	1998-08-25
EP0723777B1 (de)	2002-07-03
EP0723777A4 (de)	1997-06-25
JP3710473B2 (ja)	2005-10-26
DE69430921T2 (de)	2003-02-13
AU683092B2 (en)	1997-10-30
ES2179079T3 (es)	2003-01-16
AU7822294A (en)	1995-05-04
PT723777E (pt)	2002-11-29
DK0723777T3 (da)	2002-10-28
EP0723777A1 (de)	1996-07-31
KR100353384B1 (ko)	2002-12-28
DE69430921D1 (de)	2002-08-08
WO1995010264A1 (en)	1995-04-20
CA2173506C (en)	2006-05-09

Legal Events

Date	Code	Title	Description
2002-10-15	UEP	Publication of translation of european patent specification

Publication	Publication Date	Title
DK0723777T3 (da)	2002-10-28	Tablet indeholdende enteriske granuler
ES2262528T3 (es)	2006-12-01	Composiciones medicinales estables para administracion oral que utilizan oxidos de hierro.
AU770777B2 (en)	2004-03-04	Multilayered tablet for administration of a fixed combination of tramadol and diclofenac
HK17386A (en)	1986-03-21	Pharmaceutical formulation
IL72664A (en)	1988-03-31	Controlled release pharmaceutical compositions comprising cross-linked,porous polymers
KR890016968A (ko)	1989-12-14	약제 흡착물
KR870002832A (ko)	1987-04-13	제약 조성물
JO2555B1 (en)	2010-09-05	Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
JPH05112445A (ja)	1993-05-07	作用開始を速くし潜在特性を増加させる移送システム
EP0103387A3 (de)	1984-12-12	Langwirkende Matrix-Tabletten-Formulierungen
SK103296A3 (en)	1997-03-05	Film coated tablet of paracetamol and domperidone
US3330729A (en)	1967-07-11	Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent
IE821861L (en)	1983-02-05	Pharmaceutical compositions
IL81045A0 (en)	1987-03-31	Pharmaceutical product for the sustained release of ibuprofen and its preparation
CA2383212A1 (en)	2001-03-08	Controlled release oral dosage suitable for oral administration
EP0040472A3 (en)	1982-07-21	Spray dried n-acetyl-p-aminophenol compositions and method for manufacture thereof
RU95107880A (ru)	1997-11-10	Твердая фармацевтическая форма
DE3789258D1 (de)	1994-04-14	Multigranuläre Tablette mit verzögerter Freisetzung.
WO2004054547A1 (en)	2004-07-01	Stable topiramate formulations
CA2454449A1 (en)	2003-02-13	Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form
EP0106028A3 (de)	1985-10-30	Diuretische/blutdrucksenkende Zusammensetzungen und Verfahren zu ihrer Herstellung
KR19990082398A (ko)	1999-11-25	제산제의 사용 방법과 제산제를 배합한 약제제
JP2001187738A (ja)	2001-07-10	アスピリン含有製剤製品
US20060134193A1 (en)	2006-06-22	Method to improve pharmaceutical tablets having a matrix of cellulose ether
RU96123569A (ru)	1999-01-27	Лекарственный препарат